前收市價 | 4.5000 |
開市 | 4.5000 |
買盤 | 7.7000 |
賣出價 | 12.3000 |
拍板 | 195.00 |
到期日 | 2025-12-19 |
今日波幅 | 4.5000 - 4.5000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 79 |
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
AbbVie's (ABBV) Skyrizi is now approved for four indications across immune-mediated inflammatory diseases.